Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes-Reference-Cited by-同舟云学术

Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes

Published:2020-12 Issue:6 Volume:10 Page:532-545
ISSN:2095-1779
Container-title:Journal of Pharmaceutical Analysis
language:en
Short-container-title:Journal of Pharmaceutical Analysis

Author:

Navas Natalia,Hermosilla Jesús,Torrente-López Anabel,Hernández-Jiménez José,Cabeza Jose,Pérez-Robles Raquel,Salmerón-García Antonio

Funder

III

ERDF

University of Granada

Publisher

Elsevier BV

Subject

Analytical Chemistry,Electrochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Pharmacy

Reference41 articles.

1. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality;Zhang;Int. J. Antimicrob. Agents,2020

2. Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies;Zhao;Int. J. Antimicrob. Agents,2020

3. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?;Liu;J. Autoimmun.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review;European Journal of Clinical Pharmacology;2024-06-27

2. Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics;J PHARM ANAL;2024

3. Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics;Journal of Pharmaceutical Analysis;2023-12

4. Expediting the chromatographic analysis of COVID-19 antibody therapeutics with ultra-short columns, retention modeling and automated method development;Journal of Pharmaceutical and Biomedical Analysis;2022-11

5. A Review of Potential Therapeutic Strategies for COVID-19;Viruses;2022-10-25